Terms: = Leukemia AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1
550 results:
1. An intricate regulatory circuit between FLI1 and gata1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.
Wang C; Hu M; Yu K; Liu W; Hu A; Kuang Y; Huang L; Gajendran B; Zacksenhaus E; Xiao X; Ben-David Y
Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38695236
[TBL] [Abstract] [Full Text] [Related]
2. miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1
Sessa R; Trombetti S; Bianco AL; Amendola G; Catapano R; Cesaro E; Petruzziello F; D'Armiento M; Maruotti GM; Menna G; Izzo P; Grosso M
Open Biol; 2024 Feb; 14(2):230319. PubMed ID: 38350611
[TBL] [Abstract] [Full Text] [Related]
3. GAS5 promotes cytarabine induced myelosuppression via inhibition of hematopoietic stem cell differentiation.
Du YX; Yang J; Yan H; Liu YL; Chen XP
Toxicol Appl Pharmacol; 2024 Feb; 483():116841. PubMed ID: 38290668
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of decreased or loss of ABO blood group expression in acute myeloid leukaemia: A single-centre retrospective study.
Han JH; Lee H; Kim JK; Yoo J; Park K; Jekarl DW; Kim Y
Vox Sang; 2024 Apr; 119(4):353-362. PubMed ID: 38245834
[TBL] [Abstract] [Full Text] [Related]
5. Inherent genome instability underlies trisomy 21-associated myeloid malignancies.
Chen CC; Silberman RE; Ma D; Perry JA; Khalid D; Pikman Y; Amon A; Hemann MT; Rowe RG
Leukemia; 2024 Mar; 38(3):521-529. PubMed ID: 38245602
[TBL] [Abstract] [Full Text] [Related]
6. Establishment of the Myeloid TBX-Code Reveals Aberrant Expression of T-Box Gene TBX1 in Chronic Myeloid leukemia.
Nagel S; Haake J; Pommerenke C; Meyer C; MacLeod RAF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203204
[TBL] [Abstract] [Full Text] [Related]
7. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Hoffmeister LM; Suttorp J; Walter C; Antoniou E; Behrens YL; Göhring G; Awada A; von Neuhoff N; Reinhardt D; Schneider M
Leukemia; 2024 Mar; 38(3):538-544. PubMed ID: 38086945
[TBL] [Abstract] [Full Text] [Related]
8. Too many white cells-TAM, JMML, or something else?
Satty A; Stieglitz E; Kucine N
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):37-42. PubMed ID: 38066851
[TBL] [Abstract] [Full Text] [Related]
9. Down syndrome and leukemia: An insight into the disease biology and current treatment options.
Barwe SP; Kolb EA; Gopalakrishnapillai A
Blood Rev; 2024 Mar; 64():101154. PubMed ID: 38016838
[TBL] [Abstract] [Full Text] [Related]
10. Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia.
Liu Y; Karlsson S
Leukemia; 2024 Jan; 38(1):1-9. PubMed ID: 37973818
[TBL] [Abstract] [Full Text] [Related]
11. Synergistic roles of DYRK1A and gata1 in trisomy 21 megakaryopoiesis.
Sit YT; Takasaki K; An HH; Xiao Y; Hurtz C; Gearhart PA; Zhang Z; Gadue P; French DL; Chou ST
JCI Insight; 2023 Oct; 8(23):. PubMed ID: 37906251
[TBL] [Abstract] [Full Text] [Related]
12. Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.
Peroni E; Gottardi M; D'Antona L; Randi ML; Rosato A; Coltro G
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895004
[TBL] [Abstract] [Full Text] [Related]
13. Generation of CHOPi-008-B, a euploid iPSC line from a patient with Trisomy 21 and a gata1 mutation.
Takasaki K; Kumar SS; Gagne A; French DL; Chou ST
Stem Cell Res; 2023 Oct; 72():103198. PubMed ID: 37677872
[TBL] [Abstract] [Full Text] [Related]
14. Detection of transient abnormal myelopoiesis blasts in a liver biopsy specimen by double-immunostaining for full-length gata1 and CD42b.
Haba A; Imaizumi Y; Hayashi D; Yasue S; Otsuka H; Endo S; Ozeki M; Kobayashi K; Miyazaki T; Hara A; Ohnishi H
Hematology; 2023 Dec; 28(1):2240135. PubMed ID: 37489937
[TBL] [Abstract] [Full Text] [Related]
15. Generation of 2 isogenic clones from a patient with Trisomy 21 and a gata1 mutation.
Takasaki K; Kumar SS; Gagne A; French DL; Chou ST
Stem Cell Res; 2023 Jun; 69():103098. PubMed ID: 37084616
[TBL] [Abstract] [Full Text] [Related]
16. Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.
van den Akker TA; Liu YC; Liu H; Chapman J; Levine JM; Weinberg OK; Geyer JT
Pathobiology; 2024; 91(1):89-98. PubMed ID: 36996802
[TBL] [Abstract] [Full Text] [Related]
17. Ormeloxifene, a nonsteroidal antifertility drug promotes megakaryocyte differentiation in leukemia cell line K562.
Mishra M; Singh AK; Thacker G; Upadhyay V; Sanyal S; Trivedi AK
Cell Biol Int; 2023 Jul; 47(7):1247-1258. PubMed ID: 36950830
[TBL] [Abstract] [Full Text] [Related]
18. PAK5 is a potential target in myelodysplastic syndrome through interacting with LMO2 and gata1.
Pan X; Liu D; Ying M; Zheng G; Fan C; Pan F; Ke Q
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):77-85. PubMed ID: 36905268
[TBL] [Abstract] [Full Text] [Related]
19. A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.
Krishnan V; Schmidt F; Nawaz Z; Venkatesh PN; Lee KL; Ren X; Chan ZE; Yu M; Makheja M; Rayan NA; Lim MGL; Cheung AMS; Bari S; Chng WJ; Than H; Ouyang J; Rackham O; Tan TZ; Hwang WYK; Chuah C; Prabhakar S; Ong ST
Blood; 2023 Jun; 141(22):2738-2755. PubMed ID: 36857629
[TBL] [Abstract] [Full Text] [Related]
20. Leukemogenesis in infants and young children with trisomy 21.
Roberts I
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):1-8. PubMed ID: 36485097
[TBL] [Abstract] [Full Text] [Related]
[Next]
